Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
Verywell Health on MSN3d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...
This is due to the risks for serious adverse outcomes resulting from sedation, dissociation, respiratory depression, abuse, ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Hosted on MSN1h
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Spravato is classified as a Schedule III controlled substance and is only available through a restricted program called the Spravato REMS. The Food and Drug Administration (FDA) has approved ...
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback